Nitric oxide - An important mediator in sepsis?;Nitrogenmonoksid - En viktig mediator ved sepsis?

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 27, 1999, Pages 4061-4065

  Kirkebøen, Knut Arvid ^a   Strand, Øystein Anders ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CYTOKINE PRODUCTION; HUMAN; MACROPHAGE; NONHUMAN; PARENCHYMA; REVIEW; SEPSIS; SEPTIC SHOCK; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HEMODYNAMIC PROCESSES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SHOCK, SEPTIC;

EID: 0033544343     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340: 207-14.
2. Dal Nogare AR. Southwestern internal medicine conference: septic shock. Am J Med Sci 1991; 302: 50-65.
3. Natanson C, Hoffman WD, Suffredini AF, Eichacher PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-83.
4. Hibbs JB jr., Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867-77.
5. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, controls. Cell 1994; 78: 915-8.
6. Nava E, Palmer RMJ, Moncada S. The role of nitric oxide in endotoxin shock: effects of L-NMMA. J Cardiovasc Pharmacol 1992; 20 (suppl): 132-4.
7. Evans TE, Carpenter A, Silva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram negative sepsis. J Infect Dis 1994; 169: 343-9.
8. Kilbourne RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J et al. Reversal of endotoxin mediated shock by N-g-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 72: 1132-8.
9. Lorente JA, Landin L, Rennes E, De Pablo R, Jorge P, Rodena E et al. Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 1993; 21: 759-67.
10. Wei X, Charles IG, Smith A, Ure J, Feng GJ, Huang FF et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-11.
11. Strand Ø, Kirkebøen KA, Giercksky KE. Inhibition of nitric oxide synthase does not affect survival in a rat model of abdominal sepsis. Scand J Clin Lab Invest 1997; 57: 105-10.
12. G-methyl-L-arginine are abolished in a canine shock model using high dose endotoxin. Res Commun Chem Pathol Pharmacol 1992; 78: 57-68.
13. Fukatsu K, Saito H, Fukushima R, Inoue T, Lin MT, Inabe T et al. Detrimental effects of a nitric oxide synthase inhibitor (N-ω-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 1995; 130: 410-4.
14. Minnard J, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142-8.
15. Tracey WR, Nakane M, Basha F, Carter G. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors. Can J Physiol Pharmacol 1995; 73: 665-9.
16. Cobb JP, Natanson C, Quezado ZMN, Huffman WD, Koev CA, Banks S et al. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 1995; 268: H1634-42.
17. Wright CE, Reeves DD, Moncada S. The protective and pathological roles of nitric oxide in endotoxin shock. Cardiovase Res 1992; 26: 48-57.
18. Brandtzæg P, Kierulf P, Gaustad P, Skulberg A, Bruun IN, Halvorsen S et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
19. Casey L, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-8.
20. Lowry SF. Sepsis and its complications: clinical definitions and therapeutic prospects. Crit Care Med 1994; 22: 1-2.
21. G-monometliyl-L-arginine. Crit Care Med 1998; 26: 1490-9.
22. Cohen RI, Huberfeld S, Genovese J, Steinberg HN, Scharf SM. A comparison between the acute effects of nitric oxide synthase inhibition and fluid resuscitation on myocardial function and metabolism in endotoxemic dogs. J Crit Care 1996; 11: 26-37.
23. Brady AJB, Warran JB, Wiliams TJ, Poole-Wilson PA, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176-82.
24. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hauler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-9.
25. Schulz R, Panas DL, Catena R, Moncada S, Olye PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1 and tumor necrosis factor-α. Br J Pharmacol 1995; 114: 27-34.
26. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79: 363-80.
27. Kilbourn RG, Szabó C, Traber DL. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons from experimental and clinical studies. Shock 1997; 7: 235-46.
28. Ochoa JB, Udekwu AO, Billiar TR, Sato K, Ikeda K, Ueda S et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
29. Gomes-Jimenez J, Selgado A, Mourelle M, Martin MC, Segura RM, Peracaula R et al. L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23: 253-8.
30. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
31. Lee K, Greger XL. Consaud JR, Graham KL, Chinn BL. Nitrate, nitrite balance, and de novo synthesis of nitrate in humans consuming cured meats. Am J Clin Nutr 1986; 44, 188-94.
32. Strand ØA, Granli T, Dahl R, Bøckman OC, Kirkebøen KA. Serum nitrate levels in patients with severe sepsis and renal failure. Clin Intensive Care 1997; 8: 52-7.
33. van Dissel JT, Groenveld PH, Maes B, van Furth R, Frölich M, Fenth HOM. Nitric oxide: a predictor of morbidity in postoperative patients? Lancet 1994; 343: 1579-80.
34. Mackenzie IM, Ekangaki A, Young JD, Garrard CS. Effect of renal function on serum nitrogen oxide concentrations. Clin Chem 1996; 42: 440-4.
35. Arnalich F, Hernanz A, Jimenez M, Lopez J, Tato E, Vazquez JJ et al. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept 1996; 65: 115-21.
36. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffer A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993; 167: 1358-63.
37. Groeneveld ABJ, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery 1986; 99: 140-53.
38. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early predictors of short-term survival in human septic shock. Intensive Care Med 1996; 22: 17-25.
39. Schneider F, Lutun PH, Hasselman M, Stoclet JC, Temple JD. Methylene blue increases systemic vascular resistance in human septic shock. Intensive Care Mod 1992; 18: 309-11.
40. Preiscr JC, Lejeunne P, Roman A, Carlier E, De Bracker D, Leeman M et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995; 23: 259-64.
41. Brown G, Frankl D, Phang T. Continuons infusion of methylene blue for septic shock. Postgrad Med J 1996; 72: 612-4.
42. Daemen-Gubbels CRGH, Groeneveld PHP, Groenveld ABJ, van Kamp GJ, Bronsveld W, Thijs LG. Methylene blue increases myocardial function in septic shock. Crit Care Med 1995; 23: 1363-70.
43. Petros A, Benett D, Vallance P. Effect of nitric oxide synthase inhibitors in patients with septic shock. Lancet 1991; 338: 1557-8.
44. Petros A, Lamb G, Leone A, Moncada S, Bennet D, Vallance P. Effect of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-9.
45. Lorente JA, Landín L, DePablo R, Liste D. L-Arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287-95.
46. Saetre T, Smiseth OA, Scholz T, Carlsen H, Nordsletten L, Fahlstrøm E et al. Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am J Physiol 1996; H271: 1325-32.
47. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide in septic shock: how much is beneficial? Lancet 1991; 338: 1555-7.
48. G-monomethyl-L-arginine in cancer patients with septic shock. Endothelium 1996; 3 (suppl): 57.
49. Locker GJ, Burgmann H, Staudinger T. Fatal cardiac side effects of L-NMMA? Crit Care Med 1996; 24: 1930.
50. Duneker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 1994; 74: 629-40.
51. Altman JD, Kinn J, Duncker DJ. Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 1994; 28: 119-24.
52. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Steward DJ. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthasc mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vase Biol 1995; 15: 52-7.
53. Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRXA by shortening its half-life. Circ Res 1993; 73: 205-9.
54. Vincent J-L, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C et al. Myocardial depression characterizes the fatal course of septic shock. Surgery 1992; 111: 660-7.
55. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-7.
56. Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol 1995; 114: 363-8.
57. Kirkebøen KA, Strand ØA. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol Scand 1999; 43: 275-88.